-
Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.
firstwordpharma
August 27, 2021
Humacyte, Inc. today announced the successful completion of its business combination (the "Business Combination") with Alpha Healthcare Acquisition Corp.
-
COVID-19 vaccines highly effective against hospitalisation by Delta variant
europeanpharmaceuticalreview
June 22, 2021
An analysis shows Comirnaty® and the COVID-19 Vaccine AstraZeneca are both over 90 percent effective in preventing hospitalisation from the Delta variant.
-
Long-lasting Chlorine Dioxide (ClO2) Aqueous Solution Presented by Taiko Pharmaceutical and Kitasato University Inactivates over 99.99% of SARS-CoV-2 (COVID-19 Virus)
prnasia
June 11, 2021
Taiko Pharmaceutical Co., Ltd. based in Osaka, Japan, hereby announced that long-lasting chlorine dioxide (ClO2) aqueous solution (*1) inactivated over 99.99% of SARS-CoV-2 (COVID-19 Virus), including its Alpha and Gamma variants (*2), in a test ...
-
'Indian' variant of coronavirus now dominant strain in the UK
pharmatimes
June 04, 2021
According to Public Health England's weekly coronavirus variant cases data, cases of the Indian or Delta (VOC-21APR-02) variant in the UK have risen by 5,472 since last week to 12,431.
-
Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer
prnasia
March 09, 2021
Wugen Inc., a clinical-stage biotechnology company developing novel universal natural killer (NK) and T-cell therapies for the treatment of cancer, announced that it has entered into an exclusive license and collaboration agreement with Shanghai-based ...